Cognition Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CEOLisa R. Ricciardi
CEOLisa R. Ricciardi
Employees28
Employees28
HeadquartersPurchase, New York
HeadquartersPurchase, New York
Founded2007
Founded2007
Employees28
Employees28
CGTX Key Statistics
Market cap25.17M
Market cap25.17M
Price-Earnings ratio-0.56
Price-Earnings ratio-0.56
Dividend yield—
Dividend yield—
Average volume2.62M
Average volume2.62M
High today$0.5788
High today$0.5788
Low today$0.335
Low today$0.335
Open price$0.354
Open price$0.354
Volume14.38M
Volume14.38M
52 Week high$2.54
52 Week high$2.54
52 Week low$0.2223
52 Week low$0.2223
People also own
Based on the portfolios of people who own CGTX. This list is generated using Robinhood data, and it’s not a recommendation.